Plain-English translation of NCT06076811 on ClinicalTrials.gov ↗ · Source last updated · Translation generated · How we translate trials
Read our Colorectal Neoplasms research guide →This research study is testing a new blood test that looks for tiny traces of cancer DNA left in your bloodstream after colorectal cancer surgery. The goal is to see whether this blood test can reliably tell doctors which patients are most likely to have their cancer return, and whether it's better than the methods doctors use today. If successful, this test could help doctors decide who needs additional chemotherapy and catch cancer recurrence much earlier.
About 1 in 4 colorectal cancer patients have their cancer come back even after surgery that was meant to remove it all. Right now, doctors don't have a reliable way to figure out which patients are at highest risk or to catch recurrence early enough to treat it effectively. This blood test could solve that problem by detecting cancer cells that are still hiding in the body.
You likely qualify if…
You likely don't qualify if…
If you join this study, you will have blood drawn shortly after your colorectal cancer surgery, and again after any chemotherapy treatment you receive. The study team will track how you do over the next three years to see whether the blood test results matched your actual outcome. You'll need to be able to return for visits and blood tests at scheduled times, but there are no medications or invasive procedures involved beyond the blood draws.
AI-generated summary from trial data · Jun 3, 2026 · Not medical advice
Denmark